Evidence map›Paper›PMID 11884602›Full record

ArticleMolecular and cellular biology2002

Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABPgamma1.

Ludger Hauck, Rudolf G Kaba, Martin Lipp, Rainer Dietz, Rüdiger von Harsdorf

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The rb pathway and cancer therapeutics.Current drug targets · 2009
    Review
  6. Article
  7. Article
  8. Life and death decisions by the E2F transcription factors.Current opinion in cell biology · 2007
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ludger HauckDepartment of Cardiology, Campus Virchow Clinic, Charité, Humboldt University, Germany.
Rudolf G Kaba
Martin Lipp
Rainer Dietz
Rüdiger von Harsdorf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The E2F family of transcription factors comprises six related members which are involved in the control of the coordinated progression through the G(1)/S-phase transition of cell cycle or in cell fate decision. Their activity is regulated by pocket proteins, including pRb, p107, and p130. Here we show that E2F1 directly interacts with the ETS-related transcription factor GABPgamma1 in vitro and in vivo. The binding domain interacting with GABPgamma1 was mapped to the C-terminal amino acids 310 to 437 of E2F1, which include its transactivation and pRb binding domain. Among the E2F family of transcription factors, the interaction with GABPgamma1 is restricted to E2F1. DNA-binding E2F1 complexes containing GABPgamma1 are characterized by enhanced E2F1-dependent transcriptional activity. Moreover, GABPgamma1 suppresses E2F1-dependent apoptosis by mechanisms other than the inhibition of the transactivation capacity of E2F1. In summary, our results provide evidence for a novel pRb-independent mechanism regulating E2F1-dependent transcription and apoptosis.

Indexed as

ApoptosisCell Cycle ProteinsGene Expression RegulationAnimalsBlotting, WesternCell LineDNA-Binding ProteinsE2F1 Transcription FactorE2F Transcription FactorsElectrophoretic Mobility Shift AssayFlow CytometryGA-Binding Protein Transcription FactorHumansIn Situ Nick-End LabelingMyocardiumProtein BindingCell Cycle ProteinsDNA-Binding ProteinsE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsGA-Binding Protein Transcription FactorRepressor ProteinsTranscription Factors

Identifiers

PMID11884602
PMCPMC133701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.